The history of Sildenafil presents a complex case for observers in the drug sector. While initially a blockbuster success, generating vast sums, the intellectual property lapse and the subsequent arrival of off-brand competitors have considerably impacted income. This presents questions about the ongoing profitability of similar therapeutic proj⦠Read More